This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Somura, F. Articles by Yokota, M. Search for Related Content PubMed PubMed Citation Articles by Somura, F. Articles by Yokota, M. Related Collections Myocardial cardiomyopathy disease

(Circulation. 2001;104:658.)
© 2001 American Heart Association, Inc.

Clinical Investigation and Reports

Reduced Myocardial Sarcoplasmic Reticulum Ca²⁺-ATPase mRNA Expression and Biphasic Force-Frequency Relations in Patients With Hypertrophic Cardiomyopathy

Fuji Somura, MD; Hideo Izawa, MD, PhD; Mitsunori Iwase, MD, PhD; Yasushi Takeichi, MD; Ryoji Ishiki, MD, PhD; Takao Nishizawa, MD; Akiko Noda, PhD; Kohzo Nagata, MD, PhD; Yoshiji Yamada, MD, PhD; Mitsuhiro Yokota, MD,PhD

From the Cardiovascular Division, Department of Clinical Pathophysiology (T.N., M.Y.), the First Department of Internal Medicine (F.S., H.I., Y.T., R.I., K.N.), Nagoya University, Graduate School of Medicine, and Nagoya University School of Health Sciences (M.I., A.N.), Nagoya; and Gifu International Institute of Biotechnology (Y.Y.), Mitake, Japan.

Correspondence to Mitsuhiro Yokota, MD, PhD, FACC, Department of Clinical Laboratory Medicine, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan. E-mail myokota{at}tsuru.med.nagoya-u.ac.jp

Background—— The relationship between left ventricular (LV) contractile functional reserve and gene expression of Ca²⁺-handling proteins in patients with hypertrophic cardiomyopathy (HCM) remains to be clarified.

Methods and Results—— We calculated the maximum first derivative of LV pressure (LV dP/dt_max) and the LV pressure half-time (T_1/2) during pacing in 14 patients with nonobstructive HCM (LV ejection fraction >55%) and 7 control subjects. Endomyocardial tissue was obtained, and mRNA levels of sarcoplasmic reticulum Ca²⁺-ATPase (SERCA2), ryanodine receptor-2, phospholamban, calsequestrin, and Na⁺/Ca²⁺ exchanger were quantified by use of a real-time quantitative reverse transcription—polymerase chain reaction method. Group A consisted of 7 HCM patients who showed a progressive rise in the LV dP/dt_max with increased heart rate. Group B consisted of 7 HCM patients in whom the heart rate—LV dP/dt_max relation was biphasic at physiological pacing rates. Both the mean maximal wall thickness and the LV hypertrophy score in group B were greater than in group A (20±5 versus 15±3 mm and 7±1 versus 5±2 points, respectively). SERCA2 mRNA levels were significantly lower in group B (SERCA2/GAPDH ratio 0.34±0.15) compared with group A (0.72±0.27) and control subjects (0.85±0.47), whereas the mRNA expression of ryanodine receptor-2, phospholamban, calsequestrin, and Na⁺/Ca²⁺ exchanger were similar in all groups.

Conclusions—— These results suggest that downregulation of SERCA2 mRNA, resulting in altered Ca²⁺ handling, may contribute to impaired LV contractile reserve in HCM patients with severe hypertrophy, even in the absence of detectable baseline systolic dysfunction.

Key Words: hypertrophy • cardiomyopathy • myocardial contraction • sarcoplasmic reticulum • biopsy

This article has been cited by other articles:

				K. Unno, S. Isobe, H. Izawa, X. W. Cheng, M. Kobayashi, A. Hirashiki, T. Yamada, K. Harada, S. Ohshima, A. Noda, et al. Relation of functional and morphological changes in mitochondria to myocardial contractile and relaxation reserves in asymptomatic to mildly symptomatic patients with hypertrophic cardiomyopathy Eur. Heart J., August 1, 2009; 30(15): 1853 - 1862. [Abstract] [Full Text] [PDF]

				M. Miyachi, H. Yazawa, M. Furukawa, K. Tsuboi, M. Ohtake, T. Nishizawa, K. Hashimoto, T. Yokoi, T. Kojima, T. Murate, et al. Exercise Training Alters Left Ventricular Geometry and Attenuates Heart Failure in Dahl Salt-Sensitive Hypertensive Rats Hypertension, April 1, 2009; 53(4): 701 - 707. [Abstract] [Full Text] [PDF]

				M. Kobayashi, H. Izawa, X. W. Cheng, H. Asano, A. Hirashiki, K. Unno, S. Ohshima, T. Yamada, Y. Murase, T. S. Kato, et al. Dobutamine stress testing as a diagnostic tool for evaluation of myocardial contractile reserve in asymptomatic or mildly symptomatic patients with dilated cardiomyopathy. J. Am. Coll. Cardiol. Img., November 1, 2008; 1(6): 718 - 726. [Abstract] [Full Text] [PDF]

				X. Yan, A. J. T. Schuldt, R. L. Price, I. Amende, F.-F. Liu, K. Okoshi, K. K. L. Ho, A. J. Pope, T. K. Borg, B. H. Lorell, et al. Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1274 - H1281. [Abstract] [Full Text] [PDF]

				M. M. Riordan and S. J. Kovacs Stiffness- and relaxation-based quantitation of radial left ventricular oscillations: elucidation of regional diastolic function mechanisms J Appl Physiol, May 1, 2007; 102(5): 1862 - 1870. [Abstract] [Full Text] [PDF]

				X. W. Cheng, K. Obata, M. Kuzuya, H. Izawa, K. Nakamura, E. Asai, T. Nagasaka, M. Saka, T. Kimata, A. Noda, et al. Elastolytic Cathepsin Induction/Activation System Exists in Myocardium and Is Upregulated in Hypertensive Heart Failure Hypertension, November 1, 2006; 48(5): 979 - 987. [Abstract] [Full Text] [PDF]

				A. Hirashiki, H. Izawa, F. Somura, K. Obata, T. Kato, T. Nishizawa, A. Yamada, H. Asano, S. Ohshima, A. Noda, et al. Prognostic Value of Pacing-Induced Mechanical Alternans in Patients With Mild-to-Moderate Idiopathic Dilated Cardiomyopathy in Sinus Rhythm J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1382 - 1389. [Abstract] [Full Text] [PDF]

				K. Nagata, K. Obata, J. Xu, S. Ichihara, A. Noda, H. Kimata, T. Kato, H. Izawa, T. Murohara, and M. Yokota Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Failure in Low-Aldosterone Hypertensive Rats Hypertension, April 1, 2006; 47(4): 656 - 664. [Abstract] [Full Text] [PDF]

				L. L. Wootton and F. Michelangeli The Effects of the Phenylalanine 256 to Valine Mutation on the Sensitivity of Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPase (SERCA) Ca2+ Pump Isoforms 1, 2, and 3 to Thapsigargin and Other Inhibitors J. Biol. Chem., March 17, 2006; 281(11): 6970 - 6976. [Abstract] [Full Text] [PDF]

				S. Ohshima, S. Isobe, H. Izawa, M. Nanasato, A. Ando, A. Yamada, K. Yamada, T. S. Kato, K. Obata, A. Noda, et al. Cardiac Sympathetic Dysfunction Correlates With Abnormal Myocardial Contractile Reserve in Dilated Cardiomyopathy Patients J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2061 - 2068. [Abstract] [Full Text] [PDF]

				H. Izawa, T. Murohara, K. Nagata, S. Isobe, H. Asano, T. Amano, S. Ichihara, T. Kato, S. Ohshima, Y. Murase, et al. Mineralocorticoid Receptor Antagonism Ameliorates Left Ventricular Diastolic Dysfunction and Myocardial Fibrosis in Mildly Symptomatic Patients With Idiopathic Dilated Cardiomyopathy: A Pilot Study Circulation, November 8, 2005; 112(19): 2940 - 2945. [Abstract] [Full Text] [PDF]

				J. Xu, K. Nagata, K. Obata, S. Ichihara, H. Izawa, A. Noda, T. Nagasaka, M. Iwase, T. Naoe, T. Murohara, et al. Nicorandil Promotes Myocardial Capillary and Arteriolar Growth in the Failing Heart of Dahl Salt-Sensitive Hypertensive Rats Hypertension, October 1, 2005; 46(4): 719 - 724. [Abstract] [Full Text] [PDF]

				T. S. Kato, A. Noda, H. Izawa, A. Yamada, K. Obata, K. Nagata, M. Iwase, T. Murohara, and M. Yokota Discrimination of Nonobstructive Hypertrophic Cardiomyopathy From Hypertensive Left Ventricular Hypertrophy on the Basis of Strain Rate Imaging by Tissue Doppler Ultrasonography Circulation, December 21, 2004; 110(25): 3808 - 3814. [Abstract] [Full Text] [PDF]

				M. Iwase, H. Kanazawa, Y. Kato, T. Nishizawa, F. Somura, R. Ishiki, K. Nagata, K. Hashimoto, K. Takagi, H. Izawa, et al. Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters Cardiovasc Res, January 1, 2004; 61(1): 30 - 38. [Abstract] [Full Text] [PDF]

				O. J. Muller, M. Lange, H. Rattunde, H.-P. Lorenzen, M. Muller, N. Frey, C. Bittner, W. Simonides, H. A. Katus, and W.-M. Franz Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload Cardiovasc Res, August 1, 2003; 59(2): 380 - 389. [Abstract] [Full Text] [PDF]

				H. Izawa, M. Iwase, Y. Takeichi, F. Somura, K. Nagata, T. Nishizawa, A. Noda, T. Murohara, and M. Yokota Effect of Nicorandil on Left Ventricular End-Diastolic Pressure During Exercise in Patients with Hypertrophic Cardiomyopathy Eur. Heart J., July 2, 2003; 24(14): 1340 - 1348. [Abstract] [Full Text] [PDF]

				N. Bodyak, P. M. Kang, M. Hiromura, I. Sulijoadikusumo, N. Horikoshi, K. Khrapko, and A. Usheva Gene expression profiling of the aging mouse cardiac myocytes Nucleic Acids Res., September 1, 2002; 30(17): 3788 - 3794. [Abstract] [Full Text] [PDF]

				K. Nagata, F. Somura, K. Obata, M. Odashima, H. Izawa, S. Ichihara, T. Nagasaka, M. Iwase, Y. Yamada, N. Nakashima, et al. AT1 Receptor Blockade Reduces Cardiac Calcineurin Activity in Hypertensive Rats Hypertension, August 1, 2002; 40(2): 168 - 174. [Abstract] [Full Text] [PDF]

				J.-J. Hwang, P. D. Allen, G. C. Tseng, C.-W. Lam, L. Fananapazir, V. J. Dzau, and C.-C. Liew Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure Physiol Genomics, July 12, 2002; 10(1): 31 - 44. [Abstract] [Full Text] [PDF]